Mechanistic insights into COVID-19 mRNA vaccine-associated myocarditis: a bioinformatics analysis

Yanjie Jiang1,2, Yaxue Xie1, Yingnan You1,3

  • 1Department of Pediatrics, Shandong Provincial Hospital, Shandong University Jinan, Shandong, China.

Abstract

Insights

COVID-19 mRNA vaccine-associated myocarditis may involve immune dysregulation. Key genes CXCR3, NKG7, and GZMH are implicated, with potential therapeutic strategies identified.

Area of Science:

  • Immunology
  • Genetics
  • Pharmacology

Background:

  • COVID-19 vaccination provides public health benefits but carries risks like myocarditis.
  • Mechanisms of vaccine-associated myocarditis are not fully understood.
  • Identifying pathogenic genes and pathways is crucial for understanding this rare adverse event.

Purpose of the Study:

  • To identify potential pathogenic genes and molecular pathways associated with COVID-19 mRNA vaccine-induced myocarditis.
  • To elucidate the molecular mechanisms underlying this rare vaccine side effect.
  • To explore potential therapeutic targets for vaccine-associated myocarditis.

Main Methods:

  • Analysis of differentially expressed genes (DEGs) from myocarditis and COVID-19 vaccination cohorts.
  • Functional enrichment, protein-protein interaction (PPI) network construction, and hub gene identification.
  • Construction of transcriptional and miRNA regulatory networks, alongside therapeutic drug prediction.

Main Results:

  • Eighty shared DEGs were identified, significantly involved in immune cell-mediated responses and immune dysregulation.
  • Three hub genes (CXCR3, NKG7, GZMH) were identified as potentially involved in myocarditis pathogenesis.
  • TBX21 and STAT4 were identified as key transcriptional regulators, and hsa-mir-146a-5p as a miRNA regulator, with PhIP as a potential therapeutic agent.

Conclusions:

  • Immune dysregulation involving CXCR3, NKG7, and GZMH is implicated in post-vaccination myocarditis.
  • Bioinformatics analysis provides mechanistic insights into this rare adverse event.
  • Potential therapeutic strategies targeting identified genes warrant further investigation.